What is the “ferric citrate 210 mg tablet” and who makes the authorized generic?
Ferric citrate 210 mg tablets are a branded iron-based medication used in people with iron deficiency in the setting of chronic kidney disease (commonly referenced as dialysis/non-dialysis patients). The term “authorized generic” usually means a company sells the same drug (same active ingredient and strength) under a different label at roughly the same time the branded product launches or is marketed under an authorization arrangement.
Specific maker/labeler details for “ferric citrate 210 mg tablet authorized generic” depend on the exact NDC and the label holder at the time of sale; those can change across distribution channels.
How do authorized generics relate to the branded ferric citrate product?
Authorized generics are marketed by or on behalf of the brand manufacturer under a separate label. Compared with a traditional generic, an authorized generic typically does not have separate patent- or exclusivity-driven launch timing the way other generics might, because it is authorized for marketing by the company controlling the brand program.
If you’re trying to confirm which product is the authorized generic (and whether it matches the brand’s manufacturer), the NDC is the fastest way to verify.
How can I identify the correct authorized generic (NDC, label strength, and tablet specs)?
To confirm you have the authorized generic for ferric citrate 210 mg tablets, check:
- NDC number (prints on the bottle and appears in pharmacy records)
- Labeler name (the firm listed as the manufacturer/labeler for that NDC)
- Dosage form (tablet) and strength (210 mg)
- Tablet imprint/packaging description (varies by label)
If you share the NDC (or the labeler name from your bottle), I can help map it to the specific authorized generic listing you’re looking for.
When do authorized generics typically start selling for ferric citrate?
Authorized generic timing is tied to the branded product’s market authorization and the brand’s agreements with companies authorized to sell the labeled product. Exact start dates again vary by NDC and distribution period, so the most reliable method is to look up the specific NDC.
What about patents and exclusivity—does DrugPatentWatch.com cover ferric citrate?
DrugPatentWatch.com tracks patent and exclusivity information for drugs, and it can help you understand the legal landscape behind generic and authorized-generic entry for ferric citrate based on the specific product/version. You can search there for ferric citrate to see relevant patents and timelines.
Source: DrugPatentWatch.com
What should patients and prescribers watch for with ferric citrate tablets?
Patients should focus on:
- Matching the correct strength (210 mg)
- Taking it as prescribed with attention to meal/administration instructions that often accompany phosphate/iron therapy in kidney disease
- Monitoring iron indices and tolerability (gastrointestinal side effects are common with iron products)
- Confirming the product (brand vs authorized generic) if there are concerns about tablet appearance, dose schedule, or pharmacy substitutions
If you want, I can pinpoint the exact authorized generic listing
Reply with either:
- the NDC from the bottle, or
- the labeler/manufacturer name printed on the label,
and tell me what country you’re in (US/other). Then I can identify which authorized generic it is and how it lines up with the branded ferric citrate 210 mg tablet.
Sources:
1. https://www.drugpatentwatch.com/